Dudediligence.

Bausch Health Companies Inc

BHCNYSE · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$506,730

5 notices · 80,947 sh

Oct 2025 to Oct 2026

Reported ·

$247,836

4 sales · 1 buy · $15.6M bought

Oct 2025 to Jun 2026

The two figures cover different periods.

All 4 reported sales carry the 10b5-1 box. Together they are 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-19: Lenar Aimee J., Form 1442026-05-19: Lee Frank D., Form 1442026-03-03: Carson Seana, Form 1442026-03-02: Carson Seana, Form 1442026-02-27: Carson Seana, Form 1442025-11-25: PAULSON & CO. INC., bought2026-02-27: Carson Seana, sold2026-03-02: Carson Seana, sold2026-05-19: Lee Frank D., sold
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2026-08-19Lenar Aimee J., EVP, US Pharma$258,894
36,827 shplan 2026-05-21Form 4s on file end Jun 23144 ↗
2026-05-19Lee Frank D., Director$132,796
24,456 shplan 2025-09-03144 ↗
Form 4, 2026-05-20: sold 24,456 at $5.43Represents shares of the Issuer's common stock, no par value, sold in the open market pursuant to a Rule 10b5-1 trading plan to fund estimated tax obligations arising from a previously vested equity award granted to the Issuer's... Form 4 ↗
2026-03-03Carson Seana, EVP, General Counsel$25,503
4,420 shplan 2025-05-07no Form 4 on file144 ↗
2026-03-02Carson Seana, EVP, General Counsel$39,628
6,856 shplan 2025-05-07144 ↗
Form 4, 2026-03-03: sold 11,276 at $5.78Represents shares of common stock sold in the open market pursuant to a Rule 10b5-l plan adopted by the Reporting Person on May 7, 2025. Form 4 ↗
2026-02-27Carson Seana, EVP, General Counsel$49,909
8,388 shplan 2025-05-07144 ↗
Form 4, 2026-02-27: sold 8,388 at $5.95 Form 4 ↗